Evidence map›Paper›PMID 40496564›Full record

ArticleFrontiers in endocrinology2025

Defining the end of puberty in boys: INSL3 and the acute determinants of adult Leydig-cell functional capacity.

Bilal Tulumcu, Richard Ivell, Waleed Alhujaili, Ravinder Anand-Ivell

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bilal Tulumcu *School of Biosciences, University of Nottingham, Sutton Bonington, United Kingdom.
Richard Ivell *School of Biosciences, University of Nottingham, Sutton Bonington, United Kingdom.
Waleed AlhujailiSchool of Biosciences, University of Nottingham, Sutton Bonington, United Kingdom.
Ravinder Anand-IvellSchool of Biosciences, University of Nottingham, Sutton Bonington, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Introduction: Testicular Leydig cells are responsible for producing almost all the testosterone required by men throughout the lifespan, with reduced testosterone (hypogonadism) correlating with age-linked morbidity and mortality. Leydig cells derive from stem cells within the testes after birth. These undergo proliferation and differentiation during puberty to achieve their final adult status in young adulthood, after which there appears to be no further cell division and only very limited attrition into old age. Leydig-cell functional capacity reflects the total number and differentiation status of the Leydig-cell population within an individual and can be assessed by measuring in blood the constitutive Leydig-cell hormone insulin-like peptide 3 (INSL3). In adult men, this varies by more than 10-fold between individuals and correlates with later morbidity. Such INSL3 variance appears to have its origin already in young men, though what determines this is largely unknown. Methods: Here, we have used the ALSPAC (Avon Longitudinal Study of Parents and Children) cohort of boys and young men to estimate when the adult-type Leydig-cell population becomes established, that is, when puberty ends, and the contemporary anthropometric and lifestyle parameters that influence this. Results and discussion: At 17 years, mean INSL3 is not yet maximal, with high variance due to both longitudinal (timing of pubertal trajectory) and cross-sectional influences, whereas at 24 years, circulating INSL3 concentration has stabilized to its final adult status, even showing a small decreasing trend with age. Maximal INSL3 (i.e., peak puberty) was calculated to be at approximately 22 years in this cohort. Both contemporary body mass index and smoking status, though not inflammatory parameters, were contributory factors to INSL3 concentration. However, the major source of INSL3 variance in young men was shown to be already established at 17 years, with causative influences evidently occurring prior to this age, and showing that early life parameters are important for determining later adult health in men.

Indexed as

InsulinLeydig CellsProteinsPubertyAdolescentAdultChildHumansLongitudinal StudiesMaleYoung AdultInsulinLeydig insulin-like proteinProteinsALSPAChypogonadismINSL3Leydig cellpuberty

Identifiers

PMID40496564
PMCPMC12148858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.